Expression and mutational status of treatment-relevant targets and key oncogenes in 123 malignant salivary gland tumours
Jérôme Cros(Université Paris Cité), Cécile Badoual(Inserm), Daniel Brasnu(Sorbonne Université), Hélène Roussel(Université Paris Cité), É. Sbidian(Inserm), Hélène Blons(Délégation Paris 5), Florian Scotté(Université Paris-Saclay), Pierre Laurent‐Puig(Inserm), Stéphane Hans(Université Paris-Saclay), P Bruneval(Université Paris Cité), Éric Tartour(Centre National de la Recherche Scientifique)
Cited by 89
Related Papers
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study
|European Archives of Oto-Rhino-Laryngology|2020|2.8k
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
|New England Journal of Medicine|2003|2.1k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
|Immunity|2016|1.1k
Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019
|Journal of Internal Medicine|2020|847